Riskpilot← Back to searchSign inGet full accessWeeco ApS
APSBankruptCVR 40755357Vesterladenvej 21Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20191 employees
Revenue 2023
DKK -1,5M
-63% vs 2022
EBITDA margin
295.9%
+40% vs 2022
Equity ratio
-324.9%
Financial strength
Net profit 2023
DKK -8M
+4% vs 2022
| Revenue | DKK -1,5M | -63% |
| EBITDA | DKK -4,5M | +40% |
| Net profit | DKK -8M | +4% |
| Total assets | DKK 8,4M | -22% |
| Equity | DKK -27,3M | -42% |
| Employees | 1 | — |
Legal name
Weeco ApS
CVR number
40755357
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. september 2019
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2023-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Selskabets formål er at fremstille og sælge medicinske produkter og kosttilskud samt anden virksomhed, der efter direktionens skøn er forbundet dermed.
Address
Vesterladenvej 21
- Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenue | -4.076 | -3.570 | -4.115 | -1.507 |
| Staff expenses | -977 | -2.222 | -3.285 | -2.953 |
| EBITDA | -5.054 | -5.791 | -7.400 | -4.460 |
| Depreciation & amort. | -0 | -0 | -0 | -1.000 |
| EBIT | -5.054 | -5.791 | -7.400 | -5.460 |
| Net financials | -358 | -1.349 | -2.033 | -2.560 |
| Profit before tax | -5.411 | -7.141 | -9.433 | -8.019 |
| Tax | -0 | -1.617 | -1.071 | -0 |
| Net profit | -5.411 | -5.524 | -8.361 | -8.019 |
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Total assets | 5.999 | 9.301 | 10.804 | 8.394 |
| Equity | -5.371 | -10.895 | -19.257 | -27.276 |
| Long-term debt | 10.122 | 19.504 | 29.707 | 0 |
| Short-term debt | 1.249 | 692 | 354 | 35.670 |
| Total debt | 11.370 | 20.196 | 30.061 | 35.670 |
EBITDA margin
-445998500.0%
This company
15.8%
Market median
-2822775416% vs market
20202023
Equity ratio
-324.9%
This company
38.2%
Market median
-951% vs market
20202023
Return on equity
-801927800.0%
This company
18.4%
Market median
-4358303361% vs market
20202023
Net profit margin
-801927800.0%
This company
8.1%
Market median
-9900343310% vs market
20202023
Asset turnover
-0.18×
This company
1.12×
Market median
-116% vs market
20202023
Debt / equity
1.31×
This company
0.62×
Market median
-111% vs market
20202023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2019-09-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (5) | ||
MJ Chief Executive Officer | Chief Executive Officer | 2024 – 2025 |
ML Chief Executive Officer | Chief Executive Officer | 2019 – 2020 |
LM Unofficial title | Unofficial title | 2025 – 2025 |
CA Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
KF Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Weeco ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malte Johannes | Chief Executive Officer | 0 companies |
| Mats Lennart Håkansson | Chief Executive Officer | 0 companies |
| Lars Møgelvang Hansen | Unofficial title | 0 companies |
| Colleen Aleece Pattalochi | Chief Executive Officer | 0 companies |
| Kirsten Folden Dörger | Chief Executive Officer | 0 companies |